Cancer Immunology – Multimedia

Ok, this is the moment you have been waiting for – since the beginning of your scientific career – you finally get to vaccinate something. Download this guide for tips on how to optimize a preclinical vaccine trial.

Immunotherapy uses the body’s immune system to fight cancer. This animation explains three types of immunotherapy used to treat cancer: nonspecific immune stimulation, T-cell transfer therapy, and immune checkpoint inhibitors.

IMMUNOTHERAPY: The Path to a Cancer Cure (For Patients) explains the interplay between the immune system and cancer; mechanisms underlying immune-based agents; and different approaches to cancer immunotherapeutics.

Discover how scientists are harnessing the body's own immune system to fight cancer, and how they are using quantitative pathology solutions from PerkinElmer to better understanding the interactions between the immune system and cancer, and to identify biomarkers for translational research.

Our immune system plays a vital role in protecting us from illness and infection by fighting off invaders to our body… but when our own cells are the source of the problem, as in cancer, what then?

CAR T-cell therapy, like all forms of cancer immunotherapy, seeks to sharpen and strengthen the immune system’s inherent cancer-fighting powers. It involves treating patients with modified versions of their own immune system T cells.

Traditionally, cancer treatment has revolved around chemotherapy, radiation and surgery. But thanks to groundbreaking immune checkpoint blockade research led by Jim Allison, Ph.D., we have a new way to treat cancer: immunotherapy. Rather than treating the cancer directly, immunotherapy trains the immune system to attack cancer.

This infographic explores the various types of immunotherapy, their pros and cons and looks at some recent success stories in the field.

Here we describe a platform of T cell activation bioassays for the development of CD3 bispecific antibodies and engineered T cell immunotherapies.

Research at the University of Southampton is looking at how immunotherapy can enable the body’s immune system to recognise and kill cancer cells.